As NK cell numbers were reduced in the ADU-S100 combination compared to IL-15, despite a marked decrease in tumor cell viability in the presence of the combination treatment, we investigated the activation of NK cells and CD8 T cells with the different treatments as a possible reason for the increase in tumor cell killing. Here, CD8A is linked to neoplasm.